Human Molecular Genetics, 2003, Vol. 12, No. 2 145-153
© 2003 Oxford University Press
Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations
1Diabetes Center and Department of Medicine, University of California, San Francisco, CA 94143, USA, 2CNRS 80-90-Institute of Biology of Lille, Institute Pasteur, Lille, France, 3Pediatric Gastroenterology and Nutrition Department, Armand-Trousseau Teaching Hospital, Paris, France, 4Howard Hughes Medical Institute, 5Department of Pediatrics, Lille University Hospital, Lille, France and 6Barts and The London Genome Center, Queen Mary School of Medicine, London, UK
Received September 17, 2002; Accepted November 13, 2002
Heterozygous mutations in the coding region of the serpentine Melanocortin 4 receptor are the most common genetic cause of human obesity described to date. There are still conflicting data regarding the overall prevalence of such mutations in obesity and limited information is available on the functional defects caused by most obesity-associated MC4R mutations. We report here the screening for mutations in the coding region of the MC4R of a new cohort of 172 patients presenting with severe childhood obesity and a family history of obesity. Three heterozygous MC4R mutations (Ser127Leu, Ala244Glu and Pro299His) were found in three patients of this cohort (1.74%), confirming that such mutations are implicated in a significant number of childhood obesity cases. A functional analysis of these mutant receptors, in addition to 11 other childhood obesity-associated MC4R mutations, indicates that they all alter the activation of the receptor by the endogenous agonist
-MSH. To further examine the functional defects caused by childhood obesity-associated MC4R mutations, we developed a novel, sensitive technique to quantitatively analyze the effect of a mutation on MC4R cell surface expression. Using this method we analyzed the cell surface expression of all the 14 described childhood obesity-associated MC4R missense mutations. We demonstrate that 81.3% of childhood obesity-associated heterozygous MC4R mutations lead to intracellular retention of the receptor. This result has implications for the potential pharmacologic rescue of childhood obesity-associated MC4R mutations and for the treatment of patients presenting with this condition.
* To whom correspondence should be addressed at: University of California, San Francisco, Diabetes Center and Department of Medicine, Room HSW1113, 513 Parnassus Avenue, San Francisco, CA 94143-0573, USA. Tel: +1 4155140530; Fax: +1 4155645813; Email: vaisse{at}medicine.ucsf.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. A. Calton, B. A. Ersoy, S. Zhang, J. P. Kane, M. J. Malloy, C. R. Pullinger, Y. Bromberg, L. A. Pennacchio, R. Dent, R. McPherson, et al. Association of functionally significant Melanocortin-4 but not Melanocortin-3 receptor mutations with severe adult obesity in a large North American case-control study Hum. Mol. Genet., March 15, 2009; 18(6): 1140 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Haskell-Luevano, J. W. Schaub, A. Andreasen, K. R. Haskell, M. C. Moore, L. M. Koerper, F. Rouzaud, H. V. Baker, W. J. Millard, G. Walter, et al. Voluntary exercise prevents the obese and diabetic metabolic syndrome of the melanocortin-4 receptor knockout mouse FASEB J, February 1, 2009; 23(2): 642 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Stutzmann, K. Tan, V. Vatin, C. Dina, B. Jouret, J. Tichet, B. Balkau, N. Potoczna, F. Horber, S. O'Rahilly, et al. Prevalence of Melanocortin-4 Receptor Deficiency in Europeans and Their Age-Dependent Penetrance in Multigenerational Pedigrees Diabetes, September 1, 2008; 57(9): 2511 - 2518. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kapur, P. Samaniego, G. A. Thakur, A. Makriyannis, and M. E. Abood Mapping the Structural Requirements in the CB1 Cannabinoid Receptor Transmembrane Helix II for Signal Transduction J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 341 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Hainerova, L. H. Larsen, B. Holst, M. Finkova, V. Hainer, J. Lebl, T. Hansen, and O. Pedersen Melanocortin 4 Receptor Mutations in Obese Czech Children: Studies of Prevalence, Phenotype Development, Weight Reduction Response, and Functional Analysis J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3689 - 3696. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liu, J.-P. Fortin, M. Beinborn, and A. S. Kopin Four Missense Mutations in the Ghrelin Receptor Result in Distinct Pharmacological Abnormalities J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1036 - 1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. Farooqi and S. O'Rahilly Genetics of Obesity in Humans Endocr. Rev., December 1, 2006; 27(7): 710 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Ahn, B. Dubern, C. Lubrano-Berthelier, K. Clement, and G. Karsenty Cart Overexpression Is the Only Identifiable Cause of High Bone Mass in Melanocortin 4 Receptor Deficiency Endocrinology, July 1, 2006; 147(7): 3196 - 3202. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Kublaoui and A. R. Zinn MC4R Mutations--Weight before Screening! J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1671 - 1672. [Full Text] [PDF] |
||||
![]() |
A. Hinney, T. Bettecken, P. Tarnow, H. Brumm, K. Reichwald, P. Lichtner, A. Scherag, T. T. Nguyen, P. Schlumberger, W. Rief, et al. Prevalence, Spectrum, and Functional Characterization of Melanocortin-4 Receptor Gene Mutations in a Representative Population-Based Sample and Obese Adults from Germany J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1761 - 1769. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lubrano-Berthelier, B. Dubern, J.-M. Lacorte, F. Picard, A. Shapiro, S. Zhang, S. Bertrais, S. Hercberg, A. Basdevant, K. Clement, et al. Melanocortin 4 Receptor Mutations in a Large Cohort of Severely Obese Adults: Prevalence, Functional Classification, Genotype-Phenotype Relationship, and Lack of Association with Binge Eating J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1811 - 1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Stanley, K. Wynne, B. McGowan, and S. Bloom Hormonal Regulation of Food Intake Physiol Rev, October 1, 2005; 85(4): 1131 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-X. Tao and D. L. Segaloff Functional Analyses of Melanocortin-4 Receptor Mutations Identified from Patients with Binge Eating Disorder and Nonobese or Obese Subjects J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5632 - 5638. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Beaumont, R. A. Newton, D. J. Smit, J. H. Leonard, J. L. Stow, and R. A. Sturm Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk Hum. Mol. Genet., August 1, 2005; 14(15): 2145 - 2154. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Buono, F. Pasanisi, C. Nardelli, L. Ieno, S. Capone, R. Liguori, C. Finelli, G. Oriani, F. Contaldo, and L. Sacchetti Six Novel Mutations in the Proopiomelanocortin and Melanocortin Receptor 4 Genes in Severely Obese Adults Living in Southern Italy Clin. Chem., August 1, 2005; 51(8): 1358 - 1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Izumi, J. Inoue, S. Yokoi, H. Hosoda, T. Shibata, M. Sunamori, S. Hirohashi, J. Inazawa, and I. Imoto Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancers Hum. Mol. Genet., April 15, 2005; 14(8): 997 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
I M Heid, C Vollmert, A Hinney, A Doring, F Geller, H Lowel, H-E Wichmann, T Illig, J Hebebrand, F Kronenberg, et al. Association of the 103I MC4R allele with decreased body mass in 7937 participants of two population based surveys J. Med. Genet., April 1, 2005; 42(4): e21 - e21. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wynne, S. Stanley, B. McGowan, and S. Bloom Appetite control J. Endocrinol., February 1, 2005; 184(2): 291 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Larsen, S. M. Echwald, T. I. A. Sorensen, T. Andersen, B. S. Wulff, and O. Pedersen Prevalence of Mutations and Functional Analyses of Melanocortin 4 Receptor Variants Identified among 750 Men with Juvenile-Onset Obesity J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 219 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Zametkin, C. K. Zoon, H. W. Klein, and S. Munson Psychiatric Aspects of Child and Adolescent Obesity: A Review of the Past 10 Years Focus, October 1, 2004; 2(4): 625 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ma, P. A. Tataranni, C. Bogardus, and L. J. Baier Melanocortin 4 Receptor Gene Variation Is Associated With Severe Obesity in Pima Indians Diabetes, October 1, 2004; 53(10): 2696 - 2699. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Dempfle, A Hinney, M Heinzel-Gutenbrunner, M Raab, F Geller, T Gudermann, H Schafer, and J Hebebrand Large quantitative effect of melanocortin-4 receptor gene mutations on body mass index J. Med. Genet., October 1, 2004; 41(10): 795 - 800. [Full Text] [PDF] |
||||
![]() |
Y.-X. Tao and D. L. Segaloff Functional Characterization of Melanocortin-3 Receptor Variants Identify a Loss-of-Function Mutation Involving an Amino Acid Critical for G Protein-Coupled Receptor Activation J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3936 - 3942. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lubrano-Berthelier, C. Le Stunff, P. Bougneres, and C. Vaisse A Homozygous Null Mutation Delineates the Role of the Melanocortin-4 Receptor in Humans J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2028 - 2032. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Blondet, M. Doghman, M. Rached, P. Durand, M. Begeot, and D. Naville Characterization of Cell Lines Stably Expressing Human Normal or Mutated EGFP-Tagged MC4R J. Biochem., April 1, 2004; 135(4): 541 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Valli-Jaakola, M. Lipsanen-Nyman, L. Oksanen, A. N. Hollenberg, K. Kontula, C. Bjorbaek, and C. Schalin-Jantti Identification and Characterization of Melanocortin-4 Receptor Gene Mutations in Morbidly Obese Finnish Children and Adults J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 940 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Donohoue, Y.-X. Tao, M. Collins, G. S. H. Yeo, S. O'Rahilly, and D. L. Segaloff Deletion of Codons 88-92 of the Melanocortin-4 Receptor Gene: A Novel Deleterious Mutation in an Obese Female J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5841 - 5845. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Milligan Constitutive Activity and Inverse Agonists of G Protein-Coupled Receptors: a Current Perspective Mol. Pharmacol., December 1, 2003; 64(6): 1271 - 1276. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lubrano-Berthelier, M. Cavazos, C. Le Stunff, K. Haas, A. Shapiro, S. Zhang, P. Bougneres, and C. Vaisse The Human MC4R Promoter: Characterization and Role in Obesity Diabetes, December 1, 2003; 52(12): 2996 - 3000. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-X. Tao and D. L. Segaloff Functional Characterization of Melanocortin-4 Receptor Mutations Associated with Childhood Obesity Endocrinology, October 1, 2003; 144(10): 4544 - 4551. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hinney, S. Hohmann, F. Geller, C. Vogel, C. Hess, A.-K. Wermter, B. Brokamp, H. Goldschmidt, W. Siegfried, H. Remschmidt, et al. Melanocortin-4 Receptor Gene: Case-Control Study and Transmission Disequilibrium Test Confirm that Functionally Relevant Mutations Are Compatible with a Major Gene Effect for Extreme Obesity J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4258 - 4267. [Abstract] [Full Text] [PDF] |
||||













